Literature DB >> 20654617

Electroconvulsive seizure-induced VEGF is correlated with neuroprotective effects against cerebral infarction: Involvement of the phosphatidylinositol-3 kinase/Akt pathway.

Minoru Fujiki1, Eiji Abe, Yasuyuki Nagai, Kong Shiqi, Takeshi Kubo, Keisuke Ishii, Tatsuya Abe, Hidenori Kobayashi.   

Abstract

The present study demonstrates the cytoprotective effect of electrical convulsive stimulation (ECS) as a potential neuroprotective vascular endothelial growth factor (VEGF) inducer against ischemic insult. Phosphatidylinositol-3 kinase/Akt (PI3K/Akt) is thought to be an important factor that mediates neuroprotection. However, the signaling pathways in the brain in vivo after ECS remain unclear. We measured and compared infarction volumes to investigate the effect of ECS on cerebral infarction induced by permanent middle cerebral artery occlusion in rats. We evaluated the effects of pretreatment with Wortmannin (Wort), a specific PI3K inhibitor of ECS-induced neuroprotection against infarction volumes. To clarify the relationship between PI3K/Akt activation and neuroprotection, we used immunoblot analysis to determine the amounts of p-Akt and VEGF proteins present after ECS with or without Wort treatment. Neuroprotective effects of ECS (pretreatment with a single ECS 6h before ischemia) were prevented by Wort pretreatment, which indicates that the PI3K/Akt pathway may mediate ECS-dependent protection. ECS induced p-Akt and VEGF and ECS pretreatment enhanced ischemia-induced VEGF, both of which were prevented by Wort pretreatment. These results suggest that a single ECS induces p-Akt and that ECS plays an important role in neuroprotection against the cerebral ischemia through VEGF induction.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654617     DOI: 10.1016/j.expneurol.2010.07.010

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

Review 1.  Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy.

Authors:  Jiangling Jiang; Jijun Wang; Chunbo Li
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

2.  Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia-reperfusion injury.

Authors:  Yinying Chen; Caixiu Zhou; Yanan Yu; Jun Liu; Zhiwei Jing; Aiping Lv; Fanyun Meng; Zhong Wang; Yongyan Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-24       Impact factor: 3.000

3.  Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex.

Authors:  Se Hyun Kim; Hyun Sook Yu; Seonghoo Huh; Ung Gu Kang; Yong Sik Kim
Journal:  Psychopharmacology (Berl)       Date:  2021-10-30       Impact factor: 4.530

4.  VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures.

Authors:  Litsa Nikitidou; Irene Kanter-Schlifke; Joke Dhondt; Peter Carmeliet; Diether Lambrechts; Mérab Kokaia
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

5.  Non-invasive High Frequency Repetitive Transcranial Magnetic Stimulation (hfrTMS) Robustly Activates Molecular Pathways Implicated in Neuronal Growth and Synaptic Plasticity in Select Populations of Neurons.

Authors:  Minoru Fujiki; Kelly Matsudaira Yee; Oswald Steward
Journal:  Front Neurosci       Date:  2020-06-16       Impact factor: 4.677

6.  L-3-n-butylphthalide protects against vascular dementia via activation of the Akt kinase pathway.

Authors:  Yaping Huai; Yanhong Dong; Jing Xu; Nan Meng; Chunfeng Song; Wenbin Li; Peiyuan Lv
Journal:  Neural Regen Res       Date:  2013-07-05       Impact factor: 5.135

7.  Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model.

Authors:  Guan Qun Zhu; Seung Hwan Jeon; Kyu Won Lee; Hyuk Jin Cho; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Eun Bi Kwon; Hyo-Jin Kim; Soon Min Lee; Hey-Yon Kim; Sea Woong Kim; Woong Jin Bae
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.